Bank of New York Mellon Corp
BankPosition in XERS — Xeris Biopharma Holdings, Inc.
CIK 1390777
NEW YORK, NY
Position in XERS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,472,451
-$936,504 QoQ
Shares Held
426,285
-1.8% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 80.71008832119357.ToString("F0")%
Shared 0.ToString("F0")%
None 19.289911678806433.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $1,372,047,844 across 46 Drug Manufacturers - Specialty & Generic names. XERS ranks #26 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,899,720 | $460,985,889 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
329,148 | $195,178,172 | |
| 3 | VTRS |
Viatris Inc
|
14,128,917 | $190,881,662 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
702,492 | $92,546,288 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,809,888 | $91,170,611 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,794,432 | $54,048,287 | |
| 7 | ALKS |
Alkermes plc.
|
1,036,460 | $36,649,221 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
463,751 | $35,175,507 |
All Filings in XERS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,472,451 | 426,285 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,408,955 | 434,262 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,580,279 | 439,838 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,761,181 | 377,127 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,978,177 | 360,324 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,092,850 | 322,375 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $938,355 | 329,248 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $964,246 | 428,554 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $770,269 | 348,539 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $870,537 | 370,442 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $768,073 | 412,943 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,111,807 | 424,354 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $670,246 | 411,194 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $546,371 | 410,806 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $641,335 | 411,113 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $579,040 | 376,001 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $245,427 | 95,870 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $280,899 | 95,870 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||